Answers are grounded in this paper and cite their sources.
Biochemical analysis reveals undetectable xanthine oxidase activity in human hearts, suggesting xanthine oxidase inhibitors provide little therapeutic benefit during cardiac ischemia.
Samples from four human hearts were analyzed for both their xanthine dehydrogenase and xanthine oxidase content. We used the conventional spectrophotometric assay and a more sensitive fluorometric assay to determine the content of enzyme in these samples. In no case could any activity be detected. We conclude that human hearts must contain less than 2.0 nU/g of activity. This makes it unlikely that xanthine oxidase is a significant source of O2 free radicals in the ischemic human heart or that xanthine oxidase inhibitors will be of therapeutic value in that setting.
No takes yet. Share an insight, caveat, or question.
Eddy et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: